Association between MTHFR A1298C polymorphism and neural tube defect susceptibility: a metaanalysis - 28/02/12
Résumé |
Objective |
To determine whether 5,10-methylenetetrahydrofolate reductase A1298C polymorphism is associated with neural tube defect susceptibility.
Study Design |
Computerized literature searches of the PubMed, Embase, and Medline database were conducted to identify all eligible articles. Study subjects were classified as neural tube defect patients, mothers with neural tube defect offspring and fathers with neural tube defect offspring. The pooled odds ratios with 95% confidence interval (CI) were calculated by fixed-effects model or random-effects model.
Results |
Twenty-three case-control studies were finally included. The pooled results showed no significant association between 5,10-methylenetetrahydrofolate reductase A1298C polymorphism and neural tube defect susceptibility in any genetic contrast among the 3 groups, except 1 (AC vs AA in neural tube defect patients: odds ratio, 1.16; 95% CI, 1.10–1.32; P = .03), which, however, turned out to be of no statistical significance in the subgroup of the white population (odds ratio, 1.14; 95% CI, 0.98–1.31; P = .08).
Conclusion |
This metaanalysis suggests that 5,10-methylenetetrahydrofolate reductase A1298C polymorphism is not associated with neural tube defect susceptibility in the white population.
Le texte complet de cet article est disponible en PDF.Key words : 5,10-methylenetetrahydrofolate reductase, metaanalysis, neural tube defect, polymorphism, susceptibility
Plan
| The first 2 authors contributed equally to this work. |
|
| The authors report no conflict of interest. |
|
| Reprints not available from the authors. |
|
| Cite this article as: Wang X, Luo Y, Wang W, et al. Association between MTHFR A1298C polymorphism and neural tube defect susceptibility: a metaanalysis. Am J Obstet Gynecol 2012;206:251.e1-7. |
Vol 206 - N° 3
P. 251.e1-251.e7 - mars 2012 Retour au numéro
Article précédent
- Obstetric decision-making and counseling at the limits of viability
- Brownsyne Tucker Edmonds, Sarah Krasny, Sindhu Srinivas, Judy Shea
- Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells
- Gustavo C. Rodriguez, Jane M. Turbov, Andrew Berchuck, M. Sharon Stack, Jean A. Hurteau, Larry G. Thaete, Catherine P. Barry
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?